Item List

A-SEEDS Co., Ltd. (located in Matsumoto, Nagano Prefecture; CEO: Shigeki Yagyu, hereinafter referred to as "the Company"), is delighted to announce our selection in the Practical Application and Commercialization Phase of the third round of the 2023 Deep Tech Startup Support Project (DTSU), administered by the National Research and Development Agency, New Energy and Industrial Technology Development Organization (NEDO). This award supports our continued efforts to advance the clinical application of CAR-T cell therapy, with the goal of offering this innovative treatment to cancer patients who currently have limited therapeutic options.

A-SEEDS Co., Ltd. has achieved a significant milestone by raising 440 million yen in seed funding, contributed by Hachijuni Investment Co., Ltd. and Greencore Co., Ltd. This capital injection is pivotal in underpinning the preparatory phase for clinical trials in the United States, slated for initiation in 2024. The funds will enable technology transfers in CAR-T cell production and bolster our organizational structure and research and development capabilities. This crucial phase of funding is instrumental as we advance toward an ambitious capital mobilization to reinforce our clinical trial endeavors in the U.S.